Clinical Comparison of Two Daily Disposable Contact Lenses in a Population of Daily Disposable Contact Lens Wearers
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01233076 |
|
Recruitment Status :
Completed
First Posted : November 3, 2010
Results First Posted : September 8, 2011
Last Update Posted : July 10, 2012
|
Sponsor:
CIBA VISION
Information provided by (Responsible Party):
Alcon Research ( CIBA VISION )
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Brief Summary:
The purpose of this study is to evaluate the performance of two commercially marketed daily disposable contact lenses in a population of daily disposable contact lens wearers.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Myopia | Device: Nelfilcon A contact lens Device: Narafilcon B contact lens | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 60 participants |
| Allocation: | Randomized |
| Intervention Model: | Crossover Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Study Start Date : | October 2010 |
| Actual Primary Completion Date : | November 2010 |
| Actual Study Completion Date : | November 2010 |
Resource links provided by the National Library of Medicine
MedlinePlus Genetics related topics:
Nearsightedness
| Arm | Intervention/treatment |
|---|---|
|
Nelfilcon A / Narafilcon B
Nelfilcon A worn first, with narafilcon B worn second. Each product worn bilaterally in a daily wear, daily disposable basis for one week.
|
Device: Nelfilcon A contact lens
Commercially marketed, spherical contact lens for daily wear, daily disposable use
Other Name: DAILIES AquaComfort Plus Device: Narafilcon B contact lens Commercially marketed (US), spherical contact lens for daily wear, daily disposable use
Other Name: 1-DAY ACUVUE TruEye |
|
Narafilcon B / Nelfilcon A
Narafilcon B worn first, with nelfilcon A worn second. Each product worn bilaterally in a daily wear, daily disposable basis for one week.
|
Device: Nelfilcon A contact lens
Commercially marketed, spherical contact lens for daily wear, daily disposable use
Other Name: DAILIES AquaComfort Plus Device: Narafilcon B contact lens Commercially marketed (US), spherical contact lens for daily wear, daily disposable use
Other Name: 1-DAY ACUVUE TruEye |
Primary Outcome Measures :
- Overall Vision Quality [ Time Frame: 1 week of wear ]Overall vision quality, as interpreted by the participant and recorded on a questionnaire as a single, retrospective evaluation of 1 week of wear. Overall vision quality is evaluated binocularly and rated on a 10-point scale, with 1 being poor and 10 being excellent.
Information from the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Currently wearing daily disposable lenses in daily wear, daily disposable modality, except DAILIES AquaComfort Plus and 1-DAY ACUVUE TruEye.
- Able to wear study lenses in the available powers from -1.00D to -6.00D.
- Other protocol-defined inclusion/exclusion criteria may apply.
Exclusion Criteria:
- Eye injury within twelve weeks of enrollment.
- History of corneal or refractive surgery.
- Pre-existing ocular irritation that would preclude contact lens fitting.
- Currently enrolled in any clinical trial.
- Currently wearing DAILIES AquaComfort Plus or 1-DAY ACUVUE TruEye lenses.
- Monovision correction during the study.
- Other protocol-defined inclusion/exclusion criteria may apply.
No Contacts or Locations Provided
| Responsible Party: | CIBA VISION |
| ClinicalTrials.gov Identifier: | NCT01233076 |
| Other Study ID Numbers: |
P-337-C-034 |
| First Posted: | November 3, 2010 Key Record Dates |
| Results First Posted: | September 8, 2011 |
| Last Update Posted: | July 10, 2012 |
| Last Verified: | January 2012 |
Additional relevant MeSH terms:
|
Myopia Refractive Errors Eye Diseases |

